Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLUCIMAG: 6-DIG Scintigraphy for Insulin Resistance
NCT01493934Phase 2Completed
- Sponsor
- Inserm
- Start
- Apr 2010
- Primary completion
- Mar 2013
- Countries
- 1
01
Overview
A Phase 2 trial of 6-deoxy-6-iodo-D-glucose in type 2 diabetes mellitus (T2DM), sponsored by Inserm. Started Apr 2010; status: completed.
02
Drugs
6-deoxy-6-iodo-D-glucose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01493934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493934.